Designing immunogens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040106174A1
SERIAL NO

10326908

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides a method for designing protein immunogen, which comprises (a) modifying the amino acid sequence of the immunogen, and (b) determining whether the T-helper (Th) cell response to the modified immunogen is of the Th1 type or the Th2 type. The method is useful in identifying immunogens for use in immunotherapy of diseases. For example, chronic hepatitis is believed to be associated with a Th2-dominated response which fails to clear the virus, and switching the Th response to a Th1 response by administration of an immunogen that induces a Th1 response may help in clearing the virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLTECH PHARMA EUROPE LIMITEDSLOUGH BERKSHIRE SL1 3WE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bacon, Andrew London, GB 5 35
Douce, Gill Glasgow, GB 1 4
Jones, Christopher Berkshire, GB 255 6111
Page, Mark Munich, DE 18 272

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation